AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Radiodermatitis Treatment Market Forecast to 2023: Dominated by 3M, Acelity, ConvaTec Group, Mlnlycke Health Care, and Smith & Nephew - ResearchAndMarkets.com

May 21, 2019

DUBLIN--(BUSINESS WIRE)--May 21, 2019--

The “Global Radiodermatitis Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The radiodermatitis treatment market will register a CAGR of over 4% by 2023.

Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio.

Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period.

The rising number of public and private healthcare organizations

Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.

Advent of novel radiation equipment with fewer side-effects

The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.

Competitive Landscape

The market appears to be moderately fragmented. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover.

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

Key Players

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: DISEASE OVERVIEW

PART 06: FIVE FORCES ANALYSIS

PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY PRODUCT

PART 09: CUSTOMER LANDSCAPE

PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

PART 11: GEOGRAPHIC LANDSCAPE

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

PART 16: VENDOR ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/r/p7aynt

View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005814/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/21/2019 01:04 PM/DISC: 05/21/2019 01:04 PM

http://www.businesswire.com/news/home/20190521005814/en

All contents © copyright 2019 The Associated Press. All rights reserved.